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CARDIOLOGY

Coronary Subclavian Steal Syndrome
Rady Ho, MD, Jonathan Dunn, MD

INTRODUCTION

DISCUSSION

Coronary subclavian steal (CSS) syndrome is a rare
complication of coronary artery bypass graft surgery
(CABG) involving the left internal mammary artery (LIMA)
graft to the left anterior descending (LAD) artery.
It results from stenosis of the left subclavian artery
proximal to the LIMA, which compromises myocardial
blood flow. The incidence of CSS syndrome is between
0.1-3.4% in the United States.1 Most cases occur as a
result of long-standing subclavian stenosis due to
progres-sion of the stenosis following CABG. We report
a case of CSS syndrome, which presented as a non-ST
elevation myocardial infarction (NSTEMI).

This case highlights the difficulties that can arise in the
treatment of CSS syndrome, particularly when it is unclear
whether the pattern of ischemia is caused by the stenosis
of the subclavian artery. In this case, the defects on
echocardiogram pointed to flow limitation in the territory
of the left main coronary artery. However, angiography
revealed a patent left main. There was stenosis of the left
subclavian artery leading to flow limitation to the distal
LAD. Based on these findings, it was unclear whether the
patient’s symptoms were caused by CSS syndrome.

CASE PRESENTATION
A 76 year-old male with a past medical history of
hypertension, coronary artery disease, myocardial
infarction in 2007, left carotid artery stenosis, stroke in
2009, and end-stage renal disease on hemodialysis
presented to the emergency department with two weeks
of exertional chest pain, worsening fatigue and shortness
of breath. On the morning of presentation, he developed
chest pain at rest and came to the emergency department.
This patient was treated for myocardial infarction with a
three-vessel CABG in 2007: he had a LIMA graft to the
LAD, and saphenous vein grafts to the obtuse marginal
artery, and posterior descending artery.
On physical examination, he was found to be tachypneic,
tachycardic and hypoxic. Electrocardiogram revealed ST
segment depressions in the anterolateral leads and his
troponins were ele-vated at 2.81ng/dL. The patient was
admitted to the hospital for NSTEMI and was started on
aspirin, atorvastatin, metoprolol and a heparin infusion.
An echocardiogram revealed akinesis of the apex,
anterior septum, mid to distal inferior septum, mid to
distal anterolateral wall, distal inferior wall and mid to
distal inferolateral wall, all of which were not present on
an echocardiogram performed the previous month.
A subsequent cardiac catheterization revealed a patent
LIMA, however it showed significant stenosis of the left
subcla-vian artery proximal to the origin of the LIMA.
Although all the findings of the echocardiogram could
not be explained by the catheterization findings, the
decision was made to intervene. Angioplasty and stenting
of the left subclavian artery was performed, and this
resulted in complete resolution of his symptoms. The ST
segment normalized. Repeat echocardiogram revealed
mild to moderation left ventricular function with ejection
fraction of 40%.
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Modalities of treatment of CSS syndrome include medical
therapy alone, percutaneous intervention, and surgical
revascularization. The success rate for angioplasty and
stent placement to the subclavian artery is 80-100%. 2,3
Complication rates are reported to be between 3-6%,
with the major complication being distal embolization.2
The rate of instent restenosis is reported to be between
3-6% at 20 months.2 In contrast, surgical options such
as carotid to subclavian bypass have morbidity rates
between 15-33%, and mortality between 5-8%. 4
Currently, there are no randomized clinical trials
comparing the efficacy of one strategy versus another.
However, most agree that in the setting of symptoms,
surgical or endovascular therapy is indicated.5
In a retrospective study, Schillinger et al compared
patients treated with endovascular intervention to those
treated with medical therapy alone. The study found that
patients with ischemic symptoms were more likely to be
intervened on, and asymptomatic patients were likely to
be treated medically. However, there was no significant
difference in the number of patients with symptomatic
disease at the time of follow-up between both groups.
They concluded that in the absence of symptoms,
patients should not be intervened on based on
hemodynamic findings alone.6
For our patient, the decision was made to intervene using
percutaneous transluminal angioplasty and stenting
based on the presence of symptoms and stenosis of the
subclavian artery. He did well post-procedure and
reported remission of his symptoms. Ischemic findings
on his ECG resolved and repeat echocardiogram showed
improvement of the left ventricular function.
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